The chemical class of inhibitors that can influence the activity of KIAA1429 operates largely through indirect mechanisms, given the current understanding of these compounds. They interact with various components of the cellular methylation machinery, which can lead to a downstream effect on the methylation status of RNA, a key process that KIAA1429 is involved in. These chemicals target different aspects of methylation, either by acting as analogs that get incorporated into biological molecules and disrupt their normal function, by inhibiting enzymes responsible for adding or removing methyl groups, or by altering the availability of the universal methyl donor S-adenosylmethionine.
The diversity in the mechanisms by which these chemicals act is reflective of the complex nature of cellular methylation processes. Some of the listed compounds are known to inhibit DNA methyltransferases, which, while distinct from RNA methyltransferases, can lead to broad changes in the cellular methylation landscape and indirectly influence RNA methylation. Others target enzymes like FTO or histone methyltransferases, which signifies the interconnectedness of different methylation pathways in the cell. By influencing these pathways, these chemicals can indirectly modulate the function of proteins such as KIAA1429, which are a part of the RNA methylation machinery. The interplay between DNA methylation, histone modification, and RNA methylation is an area of active research, and these chemicals provide tools to dissect these complex relationships.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Meclofenamic Acid | 644-62-2 | sc-211780 | 5 mg | $402.00 | ||
Previously identified as an inhibitor of FTO, an m6A demethylase; could indirectly affect m6A levels and subsequently influence KIAA1429-associated pathways. | ||||||
1-Aminocyclopentanecarboxylic acid | 52-52-8 | sc-202392 | 1 g | $23.00 | ||
An amino acid analog that can inhibit S-adenosylmethionine-dependent methyltransferases indirectly by reducing S-adenosylmethionine levels. | ||||||
5′-Deoxy-5′-methylthioadenosine | 2457-80-9 | sc-202427 | 50 mg | $122.00 | 1 | |
A byproduct of polyamine biosynthesis that inhibits S-adenosylhomocysteine hydrolase, indirectly affecting methyltransferase activity. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor that could cause global hypomethylation, possibly affecting RNA methylation patterns indirectly. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
Another DNA methyltransferase inhibitor that, by altering methylation patterns, might have an indirect effect on RNA methylation and KIAA1429-related functions. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
A cytidine analog that inhibits DNA methyltransferases and could potentially influence RNA methylation indirectly. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 (free base) | sc-202651 | 5 mg | $151.00 | 4 | |
A histone lysine methyltransferase inhibitor that may have off-target effects influencing RNA methylation processes. | ||||||
Epz004777 | 1338466-77-5 | sc-507560 | 100 mg | $575.00 | ||
A selective inhibitor of DOT1L, a histone methyltransferase, which might impact methylation signaling pathways affecting KIAA1429 functionality. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A ribonucleoside analog that incorporates into RNA and inhibits RNA methylation, indirectly affecting processes KIAA1429 is involved in. | ||||||